Xilio Therapeutics, Inc. (XLO) - Quarterly Income Statement

Home
XLO
Financials

0.7 (USD) • At close June 6, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	2.93	1.724	2.263	2.357	0	2.902	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0	0	0	0	0.449	0.46	0.492	0.499	0.489	0.473	0.445	0.44	0.394	0.382	0.373	0.35	0	0	0	0
Gross Profit Numbers are in millions	2.93	1.724	2.263	2.357	0	2.453	-0.46	-0.492	-0.499	-0.489	-0.473	-0.445	-0.44	-0.394	-0.382	-0.373	-0.35	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0.742	1	0.811	0	0.845	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	8.266	8.836	10.759	11.216	10.4	11.736	11.051	13.218	16.131	14.997	13.038	16.246	14.92	11.352	10.47	17.745	11.621	17.667	11.46	9.147	5.636
General & Administrative Expenses Numbers are in millions	8.515	6.517	6.307	5.815	6.139	6.394	6.31	6.898	7.395	8.17	7.168	8.306	6.304	8.204	5.491	5.262	4.899	2.928	3.163	2.3	2.262
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	5.939	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	8.515	6.517	6.307	5.815	6.139	5.945	6.31	6.898	7.395	8.17	7.168	8.306	6.304	8.204	5.491	5.262	4.899	2.928	3.163	2.3	2.262
Other Expenses Numbers are in millions	0	0	-0.041	0.03	0.948	-2.254	0.613	0.761	0.88	0.701	0.416	-0.061	-0.129	-0.145	-0.29	-0.174	-0.147	-0.177	-0.196	0	0
Operating Expenses Numbers are in millions	16.781	15.353	17.025	17.061	17.487	17.681	17.361	20.116	23.526	23.167	20.206	24.552	21.224	19.556	15.961	23.007	16.52	20.595	14.623	11.51	8.118
Operating Income Numbers are in millions	-13.851	-13.629	-14.762	-14.704	-17.487	-18.13	-17.361	-20.116	-23.526	-23.167	-20.206	-24.552	-21.224	-19.556	-15.961	-23.007	-16.52	-20.595	-14.623	-11.447	-7.898
Operating Income Ratio Numbers are in millions	-4.727	-7.905	-6.523	-6.226	0	-6.247	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	0.586	0.536	0.742	0.779	0.284	0.475	0.613	0.761	0.88	0.701	0.416	-0.061	-0.129	-0.145	-0.29	-0.174	-0.147	-0.177	-0.196	-0.063	-0.22
Income Before Tax Numbers are in millions	-13.265	-13.093	-14.02	-13.925	-17.203	-17.655	-16.748	-19.355	-22.646	-22.466	-19.79	-24.613	-21.353	-19.701	-16.251	-23.181	-16.667	-20.772	-14.819	-11.51	-8.118
Income Before Tax Ratio Numbers are in millions	0	-7.595	-6.195	-5.908	0	-6.084	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	0	0	0	1.379	0.5	0.37	-1.379	-0.701	-0.416	0	0.129	-0.394	0	0	0	0	0	0	0
Net Income Numbers are in millions	-13.265	-13.093	-14.02	-13.925	-17.203	-17.655	-16.748	-19.355	-21.267	-21.765	-19.374	-24.613	-21.482	-19.701	-16.251	-23.181	-16.667	-20.772	-14.819	-11.51	-8.118
Net Income Ratio Numbers are in millions	0	-7.595	-6.195	-5.908	0	-6.084	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.18	-0.2	-0.22	-0.24	-0.62	-0.64	-0.61	-0.7	-0.78	-0.79	-0.71	-0.9	-0.78	-0.98	-0.61	-0.87	-0.63	-0.78	-0.56	-28	-19.85
EPS Diluted Numbers are in millions	-0.18	-0.2	-0.22	-0.24	-0.62	-0.64	-0.61	-0.7	-0.78	-0.79	-0.71	-0.9	-0.78	-0.98	-0.61	-0.87	-0.63	-0.78	-0.56	-27.98	-19.83
EBITDA Numbers are in millions	-13.354	-13.254	-14.422	-14.229	-16.096	-17.106	-16.901	-19.624	-23.027	-22.678	-19.733	-24.107	-20.784	-19.162	-15.579	-22.634	-16.17	-20.254	-14.307	-11.233	-7.987
EBITDA Ratio Numbers are in millions	-4.727	-7.688	-6.373	-6.037	0	-5.895	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Xilio Therapeutics, Inc.

NASDAQ:XLO Add to watchlist

NASDAQ:XLO